SSON European Excellence Awards Shortlist Announced

LONDON, April 26, 2017 /PRNewswire/ —

The Shared Services and Outsourcing Network (SSON) celebrates another record breaking year as the 2017 Excellence Awards shortlist is announced. The Excellence Awards are a globally recognised, annual industry awards ceremony, which honours and celebrates the Shared Servesand Service Delivery teams who have exceeded industry standards in their SS&O initiatives. This year’s ceremony will be held during the 17th Annual Shared Services and Outsourcing Week in Manchester, UK where over 600 Shared Services professionals will be in attendance.

The applicants this year are competing to win a coveted award in one of the 5 categories; Best Process Innovation, Best Shared Services Team, Excellence in Culture Creation, Excellence in Transformation, and the new for 2017 category, Excellence in Automation, sponsored by Automation Anywhere.  Across these highly competitive categories, Coca-Cola Hellenic, Tarmac, Sonae, Heathrow BSC and Shell have all made the shortlist in 2 categories, whilst other nominees include; UPM, Siemens, Hexaware, Account NI, Vodafone, Maersk, Western Union, Société Générale, Wüstenrot & Württembergische, National Grid, Ericsson, WNS, Mas Legato, 3M and Lufthansa.

After winning in 2016, Account NI have found themselves on the shortlist for the Excellence in Transformation category once again, and could to win the award for a second year in a row. They are up against entries from Coca-Cola Hellenic, Hexaware, Shell and Sonae. The 2017 Awards are judged by experts in the Shared Services industry; Irina Chernousenko, Paul Bryanhill, Chris Gunning, George Connell, Ian Herbert, Mike Stops and Paul Theaker.

The Excellence Awards Ceremony is hosted during the 17th Annual Shared Services & Outsourcing Week taking place on the 15th – 18thMay 2017 where the winners will be announced. SSOW is the premier European Shared Services Event which hosts 580+ Shared Services, GBS, Outsourcing and Transformation leaders.

For more information go to http://awards.ssoweek.com

Media contact: Sally Fletcher, +44-(0)20-7368-9809, sally.fletcher@iqpc.co.uk or visit http://awards.ssoweek.com/ 

SOURCE SSON (Shared Services & Outsourcing Network)

Interactive Projectors Market Size to Reach $4.56 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, April 26, 2017 /PRNewswire/ —

The global interactive projectors market is anticipated to reach USD 4.56 billion by 2025, according to a new report by Grand View Research, Inc. An interactive projector is an institutional tool that makes any surface interactive. It offers efficient user interaction, real-time learning, multi-touch collaboration, and PC-free interactivity and enables easy integration of materials.

     (Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )

Embedded and energy efficient projection technology offers smart devices that use gesture interface and simple touch to interact with users. The increasing adoption of e-learning in the education and corporate sector is expected to drive the demand for the interactive projector market. With the advent of faster telecommunication technologies and networking, the e-learning market is anticipated to witness a significant growth over the projected period. The developing countries like Malaysia, Vietnam, and Thailand transformed the interactive projector market into a bustling industry with vast revenue opportunities for e-learning.

The Bring Your Own Device (BYOD) market is driven by factors such as reduced hardware cost and increased proliferation of smartphones. Employees prefer using a single device for both professional and personal work to avoid theft and difficulty involved in carrying two separate devices; influencing the interactive projector demand. The increasing focus on product innovations, such as integration of projector with handheld digital cameras and mobile phones. is anticipated to improve the functionality of a projector in the education segment.

Technology obsolescence is one of the major factors expected to hinder the market demand. Furthermore, vendor-developer partnerships may pose numerous challenges. The growing need for highly developed IT infrastructure is anticipated to be a challenge for the industry demand. Additionally, the advent of these services in smartphones and tablets is projected to fuel the market demand in the upcoming years.

Browse full research report with TOC on Interactive Projector Market Analysis By Technology (DLP, 3LCD, LCoS), By Projection Distance (Standard Throw, Short Throw, Ultra-Short Throw), By Application (Education, Business, Healthcare), And Segment Forecasts, 2014 – 2025 at: http://www.grandviewresearch.com/industry-analysis/interactive-projector-market

Further key findings from the report suggest: 

  • Increasing penetration of open IoT platform that supports various applications, networks, and devices is likely to spur the market demand
  • The Liquid-Crystal-on-Silicon (LCoS) projection technology is expected to portray high growth rate with a CAGR of over 24.4% over the projected period
  • The 3LCD technology segment dominated the market in terms of revenue in 2016 as it provides higher color light output
  • The increasing focus on product innovations, such as integration with handheld digital cameras and mobile phones, is anticipated to improve projector functionalities in the education segment
  • The ultra-short throw segment is expected to have high growth rate over the forecast period
  • Various government initiatives undertaken by the emerging economies of the Asia Pacific region, to modernize the education sector, are expected to drive the market demand
  • The key players of the market include Optoma Technology, Inc. (U.S.), Delta Electronics, Inc. (Taiwan), Panasonic Corp. (Japan), and Boxlight Mimio (U.S.)

Browse related reports by Grand View Research: 

Grand View Research has segmented the interactive projector market based on technology, projection distance, application, and region: 

  • Interactive Projector Technology Outlook (Revenue, USD Million, 2014 – 2025) 
    • Digital Light Processing (DLP)
    • 3LCD
    • Liquid-Crystal-on-Silicon (LCoS)
  • Interactive Projector Projection Distance Outlook (Revenue, USD Million, 2014 – 2025) 
    • Standard throw
    • Short throw
    • Ultra-short throw
  • Interactive Projector Application Outlook (Revenue, USD Million, 2014 – 2025) 
    • Education
    • Business
    • Healthcare
    • Others
  • Interactive Projector Regional Outlook (Revenue, USD Million, 2014 – 2025) 
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
    • Asia Pacific
      • China
      • India
      • Japan
    • South America
    • The Middle East and Africa (MEA)

Read Our Blog: http://www.grandviewresearch.com/blogs/bulk-chemicals

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com

SOURCE Grand View Research, Inc.

MovieBriefs 3.0.1 is now available in the Mac App Store

[prMac.com] Charlotte, North Carolina – einstein’s legacy v2.0, LLC today is proud to announce the release and immediate availability of MovieBriefs 3.0.1, an important feature update to their popular video transformation application for OS X. MovieBriefs creates a contact sheet that summarizes all or part of your movie. The resulting image can be inspected or shared. MovieBriefs is a great tool for videographers, writers and other editorial production staff. The 3.0.1 update introduces a new workflow for creating on-demand summaries, a new project format, better high-resolution drawing and improved social media connectivity.

Cochlear Implants Market 2017 Research Forecast, Analysis and Supply Demand Report 2022

Cochlear Implants Market research report provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. Cochlear Implants Market report 2017-2022 focuses on the major drivers and restraints for the key players. The Cochlear Implants Market research report is a professional and in-depth study on the current state of Cochlear Implants Warming Devices Industry.

Browse more detail information about Cochlear Implants market report at: http://www.absolutereports.com/global-cochlear-implants-market-by-manufacturers-regions-type-and-application-forecast-to-2021-10479927

The Cochlear Implants Market Report is a meticulous investigation of current scenario of the global market, which covers several market dynamics. The Cochlear Implants market research report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2022.

A cochlear implant is a small, complex electronic device that can help to provide a sense of sound to a person who is profoundly deaf or severely hard-of-hearing. The implant consists of an external portion that sits behind the ear and a second portion that is surgically placed under the skin.

Segment by Manufacturers of Cochlear Implants Market:

  • Cochlear
  • MED-EL
  • AB(Sonova)
  • Oticon(William Demant)
  • Nurotron
  • Listent

And Others…..

Get a PDF Sample of Cochlear Implants Market Research Report at: http://www.absolutereports.com/enquiry/request-sample/10479927

The Cochlear Implants Market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market. Cochlear Implants Market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.

Cochlear Implants Market Segment by Type:

  • Unilateral
  • Binaural

Cochlear Implants Market Segment by Applications:

  • Children
  • Adults

Purchase a copy of Report @ https://www.absolutereports.com/checkout/10479927  

 

Geographical Segmentation of Cochlear Implants Market:

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America, Middle East and Africa

And Others………

The report provides a basic overview of the Cochlear Implants industry including definitions, segmentation, applications, key vendors, market drivers and market challenges. The Cochlear Implants Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status

Table of Contents

Chapter One Cochlear Implants Industry Overview

  • Cochlear Implants Definition(Product Picture and Specifications)
  • Cochlear Implants Classification and Application
  • Cochlear Implants Industry Chain Structure
  • Cochlear Implants Industry Overview
  • Cochlear Implants Industry History
  • Cochlear Implants Industry Competitive Landscape
  • Cochlear Implants Industry International and China Development Comparison

 

Chapter Two Cochlear Implants Market Data Analysis

  • Global Key Manufacturers Cochlear Implants Price List
  • Global Key Manufacturers Cochlear Implants Gross Margin List
  • Global Key Manufacturers Cochlear Implants Capacity and Market Share List
  • Global Key Manufacturers Cochlear Implants Production and Market Share List
  • Global Key Manufacturers Cochlear Implants Production Value and Market Share List

Chapter Three Cochlear Implants Technical Data Analysis

  • Global Key Manufacturers Cochlear Implants Product Quality List
  • Global Key Manufacturers Cochlear Implants Product Line Capacity and Commercial Production Date
  • Manufacturing Base(Factory) Global Regional Distribution

And continued….

Get Discount on Cochlear Implants Market Research Report at: http://www.absolutereports.com/enquiry/request-discount/10479927

Major Points from Table of Contents

1 Market Overview

2 Manufacturers Profiles

3 Global Market Competition, by Manufacturer

4 Global Market Analysis by Regions

5 North America by Countries

6 Europe by Countries

And continued….

About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

Contact–

Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email – sales@absolutereports.com

 

www.absolutereports.com

Global Gene Therapy Partnering Terms and Agreements 2010 to 2017 Summary

LONDON, April 26, 2017 /PRNewswire/ — The Global Gene Therapy Partnering Terms and Agreements 2010-2017 report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies

Download the full report: https://www.reportbuyer.com/product/3605498/

Description

The Global Gene Therapy Partnering Agreements 2010-2017 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

– Trends in gene therapy partnering deals

– Disclosed headlines, upfronts, milestones and royalties by stage of development

– Gene therapypartnering contract documents

– Top gene therapy deals by value

The Global Gene Therapy Partnering Terms and Agreements 2010-2017 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter gene therapypartnering deals. The majority of deals are early development stage whereby the licensee obtains a right or an option right to license the licensors gene therapytechnology or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest gene therapy, oligonucletides including aptamers agreements announced in the healthcare sectors.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all gene therapy partnering deals announced since 2010 including financial terms where available including over 500 links to online deal records of actual gene therapy partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

For example, analyzing actual company deals and agreements allows assessment of the following:

– What is actually granted by the agreement to the partner company? – What exclusivity is granted? – What are the precise rights granted or optioned? – What is the payment structure for the deal? – How aresalesand payments audited? – What is the deal term? – How are the key terms of the agreement defined? – How are IPRs handled and owned? – Who is responsible for commercialization? – Who is responsible for development, supply, and manufacture? – How is confidentiality and publication managed? – How are disputes to be resolved? – Under what conditions can the deal be terminated? – What happens when there is a change of ownership? – What sublicensing and subcontracting provisions have been agreed? – Which boilerplate clauses does the company insist upon? – Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? – Which jurisdiction does the company insist upon for agreement law?

The initial chapters of this report provide an orientation of Gene therapy dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Gene therapy dealmaking since 2010, including details of average headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Gene therapy deals since 2010. Deals are listed by headline value, signed by big pharma, most active Gene therapy dealmaking companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Gene therapy dealmaking with a brief summary followed by a comprehensive listing of Gene therapy deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides a comprehensive and detailed review of Gene therapy partnering deals signed and announced since Jan to 2010, where a contract document is available in the public domain. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 7 provides a comprehensive and detailed review of Gene therapy partnering deals signed and announced since Jan to 2010. The chapter is organized by specific Gene therapy technology type in focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided organized by Gene therapy partnering company A-Z, deal type definitions and Gene therapy partnering agreements example. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Gene therapy partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Gene therapy technologies and products.

Report scope

Global Gene Therapy Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to gene therapy trends and structure of deals entered into by leading companies worldwide.

Global Gene Therapy Partnering Terms and Agreements includes:

– Trends in gene therapy dealmaking in the biopharma industry since 2010 – Analysis of gene therapy deal structure – Access to headline, upfront, milestone and royalty data – Case studies of real-life gene therapy deals – Access to over 200 gene therapy deals – The leading gene therapy deals by value since 2010 – Most active gene therapy dealmakers since 2010 – The leading gene therapy partnering resources

In Global Gene Therapy Partnering Terms and Agreements, the available contracts are listed by:

– Company A-Z

– Headline value

– Stage of development at signing

– Deal component type

– Specific therapy and technology target

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Global Gene Therapy Partnering Terms and Agreements provides the reader with the following key benefits:

– In-depth understanding of gene therapy deal trends since 2010

– Access to headline, upfront, milestone and royalty data

– Analysis of the structure of gene therapy agreements with numerous real life case studies

– Comprehensive access to 200 actual gene therapy deals entered into by the world’s biopharma companies, together with real world clause examples

– Full listing of gene therapy deals by company A-Z, deal value, phase of development, deal type, and therapy focus

– Identify leading gene therapy deals by value since 2010

– Identify the most active gene therapy dealmakers since 2010

– Detailed access to actual gene therapy contracts enter into by the leading fifty bigpharma

– Insight into the terms included in gene therapy agreement, together with real world clause examples

– Understand the key deal terms companies have agreed in previous deals

– Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Download the full report: https://www.reportbuyer.com/product/3605498/

About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-gene-therapy-partnering-terms-and-agreements-2010-to-2017-summary-300445987.html

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com

Global Next Generation Sequencers – Clinical Diagnostics

LONDON, April 26, 2017 /PRNewswire/ — The Global market is additionally analyzed by the following End-Use Segments: Pharmaceutical/Biotech, Industrial, and Government/Academia. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

Download the full report: https://www.reportbuyer.com/product/4838512/

The report profiles 93 companies including many key and niche players such as –

– Agilent Technologies Inc.

– Becton, Dickinson and Company

– Fluidigm Corporation

– Genomatix GmbH

Download the full report: https://www.reportbuyer.com/product/4838512/

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting LimitationsDisclaimersData Interpretation & Reporting LevelQuantitative Techniques & AnalyticsProduct Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. OVERVIEWNext Generation Sequencing Techniques Transform the Genomics SpaceNext Generation Sequencers (NGS): A High-Throughput Sequencing TechnologyUS Leads the NGS Market, Asia-Pacific to Foster Future GrowthAcademic & Research Dominates NGS MarketOncology Testing – The Application with Most Promising Opportunities for NGS TechnologyDeclining Cost of Sequencing to Fuel Adoption of NGS SystemsTable 1: Cost Per Genome Sequencing in $ for the Years 2000 through 2016 (includes corresponding Graph/Chart)After Dramatic Price Declines, Is NGS Market Positioned for Further Disruption?2. COMPETITIVE LANDSCAPEA Highly Competitive MarketplaceIllumina Leads the Global NGS MarketIllumina’s NGS Instruments Portfolio – A ComparisonTable 2: Leading Vendors in the Global NGS Market (2016E): Percentage Breakdown of Installed Base for Illumina, Life Technologies/Thermo Fisher, and Others (includes corresponding Graph/Chart)Table 3: Leading Players in the Global NGS Instruments & Consumables Market (2016E): Percentage Breakdown of Revenues for Illumina, Life Technologies/Thermo Fisher, Pacific Biosciences and Others (includes corresponding Graph/Chart)A Glance at the Major NGS Platforms in UseKey NGS Platforms on the Market3. GROWTH DRIVERS, MARKET TRENDS & ISSUESExpanding Applications of NGS TechnologyNGS Revolutionizes Drug Discovery and Development SpaceGenetic Information offered by NGS Aids in Drug Development ProcessRevolutionary Capabilities of NGS Technology to Play a Vital Part in Advancement of Precision MedicineRising Incidences of Cancer & Benefits of Personalized Cancer Therapy to Propel NGS MarketComparison of Sanger Sequencing, Real-time PCR Sequencing and Next Generation Sequencing Methods for Identification of Driver MutationsKey Cancer StatisticsTable 4: Worldwide Incidence of Cancer: Number of New Cases Diagnosed for the Years 2013, 2020 & 2030 (includes corresponding Graph/Chart)Table 5: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)Table 6: Common Cause of Cancer Deaths Worldwide – Number of Deaths due to Select Types of Cancer for 2015 (includes corresponding Graph/Chart)NGS Emerges as a Game Changing Technology for Precision OncologyPersonalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to PatientsGrowing Significance of NGS in Enabling Personalized Oncology – Timeline of Major Developments in Sequencing Technologies & Applications Related to OncologyPersonal Genomics Services – Blessing or Bane?NGS Technology Drives RNA Sequencing in TranscriptomicsLonger Reach of a Read: A Key Feature Considered for SequencingqPCR – The Core Technique in NGS TechniqueDevelopment of New Systems & Platforms to Fuel NGS UtilizationAdvancements in Next Generation Sequencing (NGS) Technology Fuel AdoptionDevelopment Efforts Intensify in Long-Read SequencingSingle-Cell Genomics: A Promising Application of NGS TechnologyShift from Tumor Biopsies to Cancer Liquid BiopsiesNGS Enhances Study of Antimicrobial ResistanceEffective Use of NGS Tools in Public Healthcare SystemsE-Infrastructure for Storage & Analysis of NGS DataExplosive Growth in Sequencing Data Drives Focus onto Cloud ComputingNGS Hold an Edge Over CE Sequencing MethodStandardization of NGS Technique: A Critical Requirement for Wider AdoptionChallenges Confronting High-throughput Sequencing MarketHigh Machine Costs and Licensure FeesLack of Skilled PersonnelAbsence of Regulatory FrameworkLimited Access to Scientific Literature and InternetSuboptimal Outsourcing ServicesRegulations Related to NGS-Based TestsInnovative TechnologiesNanopore Sequence TechnologySingle-Molecule Real-Time technology (SMRT)Direct Genomics’ Single Molecule SequencingTruSPADES Simplifies Metagenomics SequencingGnuBIO PlatformElectron Microscopy DNA SequencingFRET-based DNA SequencingIdentification/Sequencing using Mechanical PropertiesMALDI-TOF MSRNAP Sequencing MethodTunneling Currents DNA SequencingqPCR-Driven Library Quantitation Saves Time and OverheadsAchieving Trans-Block UniformityEnhancing qPCR Precision4. TECHNOLOGY OVERVIEWSanger Sequencing (Dideoxy Sequencing)Evolution of Next Generation SequencingNGS versus MicroarraysImportant Factors to Consider Before Choosing NGS PlatformsNGS – Major Application AreasWhole Genome SequencingExome sequencingTargeted ResequencingRNA sequencing (RNA-Seq)Chromatin immunoprecipitation sequencing (ChIP-Seq)5. PRODUCT INNOVATIONS/INTRODUCTIONSQIAGEN Launches Novel QIAseq NGS PanelsBD Launches BD CLiC™ SystemImmucor and Sirona Genomics Launch MIA FORA NGSbioMérieux and Illumina Launch bioMérieux EpiSeq NGS ServiceBioline Introduces JetSeq™ Kit for NGS Sample PreparationOxford Gene Technology Launches SureSeq™ NGS SolutionsGENEWIZ Launches FuzeSeq™ Antibody Sequencing TechnologySage Science Launches PippinHT Automated Instruments for Use with NGSBGI Tech to Launch Two Ranges of NGS – X Bio and IntelligenThermo Fisher Scientific Introduces Clinical NGS Oncology Quality ControlVela Diagnostics Announces Pre-launch of Automated NGSRubicon Genomics Launches PicoPLEX™ DNA-seq Kits for Use with NGS Platforms6. RECENT INDUSTRY ACTIVITYMayo Clinic Collaborates with Illumina on NGSSophia Genetics Enters into Partnership with IlluminaNovogene Enters into Collaboration with AITbiotechNatera Extends Supply Agreement with IlluminaArcherDX Enters into Collaboration with IlluminaTBUSH to Acquire WaferGen Bio-systemsAdvanced Biological Laboratories Signs Distribution Agreement with Thermo Fisher ScientificBio-Rad Enters into Partnership with IlluminaSYGNIS AG Signs Distribution Agreement with LucigenAlmac Diagnostics Enters into Collaboration with IlluminaRoche Acquires Kapa BiosystemsQIAGEN Expands Partnership with BGIIntel Enters into Partnership with Edico GenomeIllumina Enters into Partnership with Merck SeronoLockheed Martin and Illumina Enter into PartnershipWuXi PharmaTech Acquires NextCODE HealthRoche Acquires Bina TechnologiesCollabRx Enters into Partnership with CartageniaNew England Biolabs and Directed Genomics Enter into PartnershipReprogenetics Partners with IlluminaBD Acquires GenCell BiosystemsAB SCIEX and Illumina Enter into OneOmics™ Partnership ProjectThermo Fisher Scientific, GSK, and Pfizer Enter into Agreement to Develop NGSAstraZeneca Collaborates with IlluminaRoche Acquires Genia Technologies7. FOCUS ON SELECT GLOBAL PLAYERSAgilent Technologies Inc. (US)Becton, Dickinson and Company (BD) (US)Fluidigm Corporation (US)Genomatix GmbH (Germany)Illumina, Inc. (US)Oxford Gene Technology (UK)Oxford Nanopore Technologies (UK)Pacific Biosciences of California, Inc. (US)QIAGEN N.V. (The Netherlands)RainDance Technologies, Inc. (US)Roche Sequencing (US)Shenzhen BGI Diagnosis Co., Ltd. (China)Thermo Fisher Scientific, Inc. (US)8. GLOBAL MARKET PERSPECTIVETable 7: World Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 8: World Historic Review for Next Generation Sequencers by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 9: World 14-Year Perspective for Next Generation Sequencers by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart)Table 10: World Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use Industry – Pharmaceuticals/Biotech, Industrial, and Government/Academia Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 11: World Historic Review for Next Generation Sequencers by End-Use Industry – Pharmaceuticals/ Biotech, Industrial, and Government/Academia Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 12: World 14-Year Perspective for Next Generation Sequencers by End-Use Industry – Percentage Breakdown of Dollar Sales for Pharmaceuticals/Biotech, Industrial, and Government/Academia Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATESA.Market AnalysisMarket OverviewFDA Regulations on NGS-Based TestsSequencing Applications Drive the US Genomics MarketNGS for Clinical Oncology – A Promising Area of GrowthProduct LaunchesStrategic Corporate DevelopmentsSelect Key PlayersB.Market AnalyticsTable 13: US Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 14: US Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)2. CANADAMarket AnalysisTable 15: Canadian Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 16: Canadian Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)3. JAPANA.Market AnalysisCurrent and Future AnalysisStrategic Corporate DevelopmentB.Market AnalyticsTable 17: Japanese Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 18: Japanese Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)4. EUROPEA.Market AnalysisMarket OverviewB.Market AnalyticsTable 19: European Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region/Country – France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 20: European Historic Review for Next Generation Sequencers by Geographic Region/Country – France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 21: European 14-Year Perspective for Next Generation Sequencers by Geographic Region/Country – Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart)

4a. FRANCE

Market Analysis

Table 22: French Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 23: French Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4b. GERMANYA.Market AnalysisCurrent and Future AnalysisGenomatix GmbH – A Key PlayerB.Market AnalyticsTable 24: German Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 25: German Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4c. ITALY

Market Analysis

Table 26: Italian Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 27: Italian Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOMA.Market AnalysisCurrent and Future AnalysisProduct LaunchStrategic Corporate DevelopmentSelect Key PlayersB.Market AnalyticsTable 28: UK Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 29: UK Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4e. SPAIN

Market Analysis

Table 30: Spanish Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 31: Spanish Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4f. RUSSIAMarket AnalysisTable 32: Russian Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 33: Russian Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

A.Market Analysis

Current and Future Analysis

Product Launch

Strategic Corporate Developments

QIAGEN N.V. (Netherlands) – A Key Player

B.Market Analytics

Table 34: Rest of European Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 35: Rest of European Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFICMarket AnalysisTable 36: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region/Country – China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 37: Asia-Pacific Historic Review for Next Generation Sequencers by Geographic Region/Country – China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 38: Asia-Pacific 14-Year Perspective for Next Generation Sequencers by Geographic Region/Country – Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart)

5a. CHINA

A.Market Analysis

Current and Future Analysis

Strategic Corporate Development

Shenzhen BGI Diagnosis Co., Ltd. – A Key Player

B.Market Analytics

Table 39: Chinese Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 40: Chinese Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFICA.Market AnalysisCurrent and Future AnalysisStrategic Corporate DevelopmentB.Market AnalyticsTable 41: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 42: Rest of Asia-Pacific Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)6. LATIN AMERICAMarket AnalysisTable 43: Latin American Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region/Country – Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 44: Latin American Historic Review for Next Generation Sequencers by Geographic Region/Country – Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)Table 45: Latin American 14-Year Perspective for Next Generation Sequencers by Geographic Region/Country – Percentage Breakdown of Dollar Sales for Brazil, and Rest of Latin America Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart)7. REST OF WORLDMarket AnalysisTable 46: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)Table 47: Rest of World Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 93 (including Divisions/Subsidiaries – 104) The United States (61) Canada (3) Japan (2) Europe (27) – France (1) – Germany (7) – The United Kingdom (5) – Rest of Europe (14) Asia-Pacific (Excluding Japan) (11)

Download the full report: https://www.reportbuyer.com/product/4838512/

About Reportbuyer

Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

http://www.reportbuyer.com

For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-next-generation-sequencers—clinical-diagnostics-300445990.html

SOURCE ReportBuyer

Related Links

http://www.reportbuyer.com

HIPPO’s Molecular Balancing Act Helps Nerves Not Short Circuit

CINCINNATI, April 26, 2017 /PRNewswire-USNewswire/ — Scientists write in Nature Communications it may be possible to therapeutically fine tune a constantly shifting balance of molecular signals to ensure the body’s peripheral nerves are properly insulated and functioning normally. In a study published April 26, they suggest this may be a way to treat neuropathies or prevent the development of peripheral nerve sheath tumors.

The study was led by researchers at Cincinnati Children’s Hospital Medical Center. It sought to identify the genetic and molecular networks that control the balanced proliferation and differentiation of Schwann cells in peripheral nerves – a question that so far has remained unanswered. Schwann cells form a protective myelin sheath around nerves, which acts as insulation to ensure rapid transmission of neural signals to limbs and other parts of the body.

The researchers discovered that genetic dysfunction in what they call the HIPPO-TAZ/YAP and Gαs-protein feedback circuit disrupts the balanced production of Schwann cells.

If Schwann cell numbers are too sparse and widely-spaced, insufficient insulating myelin forms around nerves, leading to nerve insulation defects in the peripheral nerves of laboratory mice. An overabundance of Schwann cells in people with the genetic disorder neurofibromatosis 1 and 2 (who have mutations in the NF1 or NF2 tumor suppressor gene) has been linked to development of nerve sheath tumors.

„These findings will lead to future studies aimed at modulating or fine tuning the dynamic balance between YAP/TAZ and Gαs, and this may lead to new therapeutic strategies,” said Q. Richard Lu, PhD, co-lead investigator and scientific director of the Brain Tumor Center at Cincinnati Children’s. „These strategies would focus on promoting myelination in the peripheral nervous system for neuropathic disease or inhibiting Schwann cell over-proliferation that occurs during formation of peripheral nerve sheath tumors like neurofibromas.”

Collaborating on the study was co-lead investigator Mei Xin, PhD, and co-first authors Yaqi Deng, PhD and Lai Man Natalie Wu, PhD (all in the Division of Experimental Biology and Cancer Biology at Cincinnati Children’s).

The researchers stress that, because the study was conducted with mice, additional research is required before it can confirmed whether the data will apply directly to human health.

Affects 20 million people

An estimated 20 million people in the United States have some form of peripheral neuropathy, according to the National Institute of Neurological Disorders and Stroke.

The condition develops as a result of damage to the peripheral nervous system, a large network that transmits information between the central nervous system to other parts of the body. Symptoms can range from numbness, tingling, pricking sensations or muscle weakness. Some neuropathic conditions can become quite severe leading to paralysis.

HIPPO Pathway

The HIPPO molecular pathway works as a tumor suppressor that helps control organ development and size in most organisms, from fruit flies to humans. It exerts this control by regulating cell proliferation and transformation into specific organ cell types. When the pathway becomes dysregulated – as in during genetic mutation – it helps drive the development of tumors.

To understand how the HIPPO pathway controls Schwann cell proliferation and myelination, the researchers used genome-wide screens.  This allowed them to identify specific genes that are turned on or off by co-regulators of gene function called TAZ and YAP in the nucleus of developing mouse Schwann cells. The molecules – YAP (Yes-associated protein) and TAZ (PDZ-binding motif) – are critical regulators of downstream genes and proteins that are important for the expansion and specification of myelin-forming Schwann cells.

The researchers also performed a transcriptome analysis comparing peripheral nerves with or without TAZ/YAP. This tells researchers which genes or signaling pathways are controlled by TAZ/YAP.

Gene occupancy and transcriptome tests revealed that, in immature Schwann cells, TAZ suppresses the expression of the gene that encodes the Gαs protein. When a Schwann cell is reaching maturity, the Gαs protein opposes the activities of TAZ and YAP. This decelerates cell expansion and allows the cells to develop and form myelin around peripheral nerves.

Combined, the molecular processes involving the HIPPO/TAZ/YAP and Gαs feedback circuit indicate it acts as a fulcrum that balances Schwann cell proliferation and differentiation in peripheral nerves, according to the authors. The finding also opens up new therapeutic avenues that can modulate and fine tune the processes to treat associated medical conditions.

Funding support for the research came in part from grants awarded by the National Institutes of Health (R01NS075243, R37NS096359), from the National Multiple Sclerosis Society (NMSS-4727) and from the National Natural Science Foundation of China.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hippos-molecular-balancing-act-helps-nerves-not-short-circuit-300445434.html

SOURCE Cincinnati Children’s Hospital Medical Center

Related Links

http://www.cincinnatichildrens.org

TAVHealth Employees Participated in Any Baby Can Walk for Autism

SAN ANTONIO, April 26, 2017 /PRNewswire/ — TAVHealth, an organization that offers a cloud-based collaborative platform that solves for Social Determinants of Health, supported the 13th Annual Any Baby Can Walk For Autism on April 22, 2017.  The walk, held at the Helotes Cornyval Grounds, was well attended and exceeded expectations. TAVHealth matched its employee’s donations and combined, the organization donated more than $1,200 to Any Baby Can.

TAVHealth partners with Autism Lifeline Links (ALL), a not-for-profit organization that works to break down barriers to care by offering a single point of entry into a coordinated network of services and care. Thousands of individuals and families struggling with Autism are able to access valuable resources and connect with others. TAVHealth created the collaborative platform that connects families with networks of clinicians, social and community services.

TAVHealth employees, and their families, participated in the Any Baby Can fund-raising walk. Katy Dice, Controller for TAVHealth, commented, „TAVHealth’s mission is to help people improve lives and we are committed to helping everyone overcome barriers to health – including individuals and families struggling with Autism. We were excited to join in the walk among thousands of enthusiastic supporters.”

Any Baby Can provides free services to children in the 19 counties surrounding the city of San Antonio and ALL provides local resources to better manage diagnoses within the spectrum of Autism. The platform and website created by TAVHealth is the first of its kind in Autism treatment and makes finding resources, answers, and support an easier process. This allows everyone to understand the person and their support system, and to build relationships characterized by care, concern, and compassion.

About TAVHealth
TAVHealth offers collaborative software and service solutions to solve for Social Determinants of Health. TAV connects the power of people, community resources, and technology to improve health outcomes and experiences, while reducing the costs of care. TAVHealth has more than 275,000 providers and close to 4 million members, families, and friends in the TAVConnect collaborative platform. To learn more about TAV, visit www.tavhealth.com

TAVHealth Media Contact
Chris Buckley, Vice President of Marketing
Chris.buckley@tavhealth.com 
619-993-3352

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tavhealth-employees-participated-in-any-baby-can-walk-for-autism-300445798.html

SOURCE TAVHealth

Related Links

http://tavhealth.com

Global Pharmaceutical Warehousing Market – Analysis, Technologies & Forecasts to 2021 – Increased Demand for Pharmaceutical Products – Research and Markets

The global pharmaceutical warehousing market to grow at a CAGR of 4.85% during the period 2017-2021.

The report, Global Pharmaceutical Warehousing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

The latest trend gaining momentum in the market is energy-efficient warehouses. Energy-efficient warehouses have improved operational efficiency with low operating costs. These warehouses provide highly innovative inventory tracking methods and value-added services, such as repackaging and quality control testing.

According to the report, one of the major drivers for this market is increased demand for pharmaceutical products. Due to the rise in generic and branded drug production, improvement in drug research, availability of high-potency drugs, and innovation in drug manufacturing processes, there is an increased demand for pharmaceutical products worldwide. High-quality medicines available in local medical retail store outlets increase accessibility for the customers.

Further, the report states that one of the major factors hindering the growth of this market is capital-intensive business. The global pharmaceutical warehousing market is capital-intensive and requires high capital infrastructure in terms of large storage space facilities. With the increase in demand for value-added services and specialized professional supply chain solutions in the logistics market, the industry is becoming highly competitive in terms of the pricing of services.

Key vendors

  • Agility
  • DB Schenker
  • DHL
  • Kuehne+Nagel
  • UPS

Other prominent vendors

  • BDP International
  • XPO Logistics
  • FedEx Supply Chain
  • GEODIS
  • CEVA Logistics
  • NFI
  • DSC Logistics
  • Others

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by service type

PART 07: Geographical segmentation

PART 08: Decision framework

PART 09: Drivers and challenges

PART 10: Market trends

PART 11: Vendor landscape

PART 12: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/mq9ffg/global

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-pharmaceutical-warehousing-market—analysis-technologies–forecasts-to-2021—increased-demand-for-pharmaceutical-products—research-and-markets-300444946.html

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

CAD/CAM Dental Systems Market Dynamics, Forecasts to 2022, Sales and Revenue Analysis Report 2017

CAD/CAM Dental Systems Market research report provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. CAD/CAM Dental Systems Market report 2017-2022 focuses on the major drivers and restraints for the key players. The CAD/CAM Dental Systems Market research report is a professional and in-depth study on the current state of CAD/CAM Dental Systems Warming Devices Industry.

Browse more detail information about CAD/CAM Dental Systems market report at: http://www.absolutereports.com/global-cad-cam-dental-systems-market-by-manufacturers-regions-type-and-application-forecast-to-2021-10479925    

The CAD/CAM Dental Systems Market Report is a meticulous investigation of current scenario of the global market, which covers several market dynamics. The CAD/CAM Dental Systems market research report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2022.

CAD/CAM Dental Systems is a field of dentistry and prosthodontics using CAD/CAM (computer-aided design and computer-aided manufacturing) to improve the design and creation of dental restorations, especially dental prostheses, including crowns, crown lays, veneers, inlays and onlays, fixed bridges, dental implant restorations, dentures (removable or fixed), and orthodontic appliances.

Segment by Manufacturers of CAD/CAM Dental Systems Market:

  • Sirona
  • 3M
  • Kavo
  • Nobel Biocare
  • Straumann
  • PLANMECA
  • Roland
  • Worknc
  • Imes-icore
  • Dentsply

And Others…..

Get a PDF Sample of CAD/CAM Dental Systems Market Research Report at: http://www.absolutereports.com/enquiry/request-sample/10479925

The CAD/CAM Dental Systems Market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market. CAD/CAM Dental Systems Market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.

CAD/CAM Dental Systems Market Segment by Type:

  • Ceramics
  • Resin
  • Other

CAD/CAM Dental Systems Market Segment by Applications:

  • Restorations
  • Implant dentistry
  • Orthodontics

Purchase a copy of Report @ https://www.absolutereports.com/checkout/10479925  

 

Geographical Segmentation of CAD/CAM Dental Systems Market:

  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America, Middle East and Africa

And Others………

 The report provides a basic overview of the CAD/CAM Dental Systems industry including definitions, segmentation, applications, key vendors, market drivers and market challenges. The CAD/CAM Dental Systems Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status

Table of Contents

Chapter One CAD/CAM Dental Systems Industry Overview

  • CAD/CAM Dental Systems Definition(Product Picture and Specifications)
  • CAD/CAM Dental Systems Classification and Application
  • CAD/CAM Dental Systems Industry Chain Structure
  • CAD/CAM Dental Systems Industry Overview
  • CAD/CAM Dental Systems Industry History
  • CAD/CAM Dental Systems Industry Competitive Landscape
  • CAD/CAM Dental Systems Industry International and China Development Comparison

 

Chapter Two CAD/CAM Dental Systems Market Data Analysis

  • Global Key Manufacturers CAD/CAM Dental Systems Price List
  • Global Key Manufacturers CAD/CAM Dental Systems Gross Margin List
  • Global Key Manufacturers CAD/CAM Dental Systems Capacity and Market Share List
  • Global Key Manufacturers CAD/CAM Dental Systems Production and Market Share List
  • Global Key Manufacturers CAD/CAM Dental Systems Production Value and Market Share List

Chapter Three CAD/CAM Dental Systems Technical Data Analysis

  • Global Key Manufacturers CAD/CAM Dental Systems Product Quality List
  • Global Key Manufacturers CAD/CAM Dental Systems Product Line Capacity and Commercial Production Date
  • Manufacturing Base(Factory) Global Regional Distribution
  • Global Key Manufacturers CAD/CAM Dental Systems R&D Status and Technology Sources

And continued….

 

Get Discount on CAD/CAM Dental Systems Market Research Report at: http://www.absolutereports.com/enquiry/request-discount/10479925

List of Figures, Tables and Charts Available in CAD/CAM Dental Systems Market report:

Major Points from Table of Contents

1 Market Overview

2 Manufacturers Profiles

3 Global Market Competition, by Manufacturer

4 Global Market Analysis by Regions

5 North America by Countries

6 Europe by Countries

7 Asia-Pacific by Countries

8 Latin America, Middle and Africa by Countries

9 Market Segment by Type

10 Market Segment by Application

11 Market Forecast (2016-2021)

12 Sales Channel, Distributors, Traders and Dealers

13 Appendix

And continued….

About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

Contact–

Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email – sales@absolutereports.com

 

www.absolutereports.com